Birch Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Birch Capital Management's RMD Position: Q3 2026 in Review
Birch Capital Management increased its ResMed (RMD) stake by 2.5% in Q3 2026, buying an estimated $145K and bringing the position to 27,306 shares worth $6.04M. The position accounts for 2.83% of the portfolio, ranked #14.
Birch Capital Management first reported a position in RMD in Q4 2019 and has held it in 28 quarters since. The position peaked at $9.7M in Q3 2025. 442 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Birch Capital Management held 27,306 shares of ResMed worth $6.04M as of Q3 2026.
- Birch Capital Management bought 665 ResMed shares in Q3 2026, an estimated $145K.
- ResMed made up 2.83% of Birch Capital Management's portfolio in Q3 2026, its #14 holding.
- Birch Capital Management first reported a position in ResMed in Q4 2019 and has held it in 28 quarters since.
- Birch Capital Management's ResMed position peaked at $9.7M in Q3 2025.
- 442 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Birch Capital Management's 13F filing for Q3 2026, filed 27 Oct 2026.